Veradermics (MANE) Share-based Compensation (2025)

Veradermics (MANE) posted Share-based Compensation of $213000.0 for Q1 2025.

Veradermics (MANE) Share-based Compensation (2025) Analysis & Trends

Veradermics' Share-based Compensation history runs 1 years deep, the most recent figure standing at $213000.0 for Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 6.39 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 9.26 Mn
4 NuCana 279.75 Bn 279.75 Bn - 1.18 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 166.40 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 257.40 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 87.30 Mn
10 Veradermics 2.63 Bn 2.63 Bn - -

Historic Data

Download Data
DateValue
Mar 31, 2025 213,000.00
Mar 31, 2025 213,000.00